David Bushnell
4 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| A Safety Study of 212Pb-VMT-alpha-NET in Patients With Neuroendocrine Tumors (NCT06148636) | David Bushnell | 2023-11-10 |
| A Clinical Trial Evaluating the Safety of Combining Lutathera(R) and Azedra(R) to Treat Mid-gut Neuroendocrine Tumors (NCT04614766) | David Bushnell | 2022-09-30 |
Track David Bushnell automatically
Every clearance here is in the API, with alerts when new ones post.